サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1540812

バイオプロセスバリデーション市場レポート：試験タイプ、プロセスコンポーネント、エンドユーザー、地域別2024-2032

Bioprocess Validation Market Report by Test Type, Process Component, End User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 137 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
バイオプロセスバリデーション市場レポート：試験タイプ、プロセスコンポーネント、エンドユーザー、地域別2024-2032
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオプロセスバリデーション市場の世界市場規模は2023年に3億6,390万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに7億2,160万米ドルに達し、2024年から2032年の間に7.66％の成長率（CAGR）を示すと予測しています。

バイオプロセスバリデーションとは、製品の製造・試験中に実施される様々な手順、プロセス、活動を実証することにより、あらゆる段階で望ましいコンプライアンスレベルを維持するための証拠書類を取得するアプローチを指します。標準的な方法として、抽出試験、微生物試験、適合性試験、完全性試験、物理化学的試験があります。これらの技術は、生物学的製剤や動物用医薬品の開発において、複数の医薬品有効成分（API）や、エンドトキシン、マイコプラズマ、細菌を含む可能性のある汚染物質の評価に役立ちます。これとは別に、バイオプロセスバリデーションは費用対効果が高く、実務や医薬品の製造手順を監視することができます。その結果、医薬品の品質、安全性、有効性、および所定の属性を保証するために、製薬会社、バイオ医薬品会社、開発・製造受託機関（CMO）によって利用されています。

バイオプロセスバリデーション市場動向：

病院や診療所において、適正製造規範（GMP）の遵守を維持するためにバイオプロセスバリデーションサービスをアウトソーシングする必要性が高まっていることが、市場の成長を大きく後押ししています。さらに、各国政府による厳格な品質・製品安全規制の施行もこれを後押ししています。さらに、さまざまな慢性疾患の有病率の上昇とバイオ医薬品に対する需要の高まりが、ヘルスケア部門全体でバイオプロセスバリデーションの広範な採用を補完しており、市場成長を後押ししています。さらに、製薬企業やCMO企業が、特にCOVID-19の期間中、新規ワクチンやバイオシミラーの製造中に医薬品の正確性、純度、効率、安全性を監視するためにバイオプロセスバリデーションを広範に使用していることも、成長を促進する要因として作用しています。これに伴い、バイオ製造インフラにおける大幅な技術進歩や、費用対効果が高くスケーラブルな医薬品製造を保証するためのバイオリアクターのバイオプロセス検証の進行が、市場の成長を後押ししています。これとは別に、臨床検査サービスのアウトソーシングの新たな傾向、個別化医薬品のニーズの高まり、医薬品の最適な品質を確保するための継続的な研究開発（R&D）活動が、市場に明るい展望をもたらしています。

本レポートで扱う主な質問

  • 世界のバイオプロセスバリデーション市場の市場規模は？
  • 2024-2032年の世界のバイオプロセスバリデーション市場の予想成長率は？
  • 世界のバイオプロセスバリデーション市場を牽引する主要因は何か？
  • 世界のバイオプロセスバリデーション市場に対するCOVID-19の影響は？
  • バイオプロセスバリデーション市場の試験タイプ別の内訳は？
  • バイオプロセスバリデーション市場のプロセスコンポーネント別の内訳は？
  • バイオプロセスバリデーション市場のエンドユーザー別の内訳は？
  • 世界のバイオプロセスバリデーション市場における主要地域は？
  • 世界のバイオプロセスバリデーション市場における主要企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界のバイオプロセスバリデーション市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：試験タイプ別

  • 抽出物試験サービス
    • 市場動向
    • 市場予測
  • 微生物学的試験サービス
    • 市場動向
    • 市場予測
  • 生理化学試験サービス
    • 市場動向
    • 市場予測
  • 完全性試験サービス
    • 市場動向
    • 市場予測
  • 互換性試験サービス
    • 市場動向
    • 市場予測
  • その他試験サービス
    • 市場動向
    • 市場予測

第7章 市場内訳：プロセスコンポーネント別

  • フィルターエレメント
    • 市場動向
    • 市場予測
  • メディアコンテナとバッグ
    • 市場動向
    • 市場予測
  • 凍結・解凍処理バッグ
    • 市場動向
    • 市場予測
  • ミキシングシステム
    • 市場動向
    • 市場予測
  • バイオリアクター
    • 市場動向
    • 市場予測
  • 転送システム
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 製薬・バイオテクノロジー企業
    • 市場動向
    • 市場予測
  • 契約開発製造組織
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Almac Group
    • Biozeen
    • Doc S.R.L.
    • Eurofins Scientific
    • Hangzhou Anow Microfiltration Co. Ltd.
    • Hangzhou Cobetter Filtration Equipment Co. Ltd.
    • Hangzhou Tianshan Precision Filter Material Co. Ltd.
    • Meissner Filtration Products, Inc.
    • Merck KGaA
    • Sartorius AG
    • SGS SA
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Bioprocess Validation Market: Major Drivers and Challenges
  • Figure 2: Global: Bioprocess Validation Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Bioprocess Validation Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: Bioprocess Validation Market: Breakup by Process Component (in %), 2023
  • Figure 6: Global: Bioprocess Validation Market: Breakup by End User (in %), 2023
  • Figure 7: Global: Bioprocess Validation Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Bioprocess Validation (Extractables Testing Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Bioprocess Validation (Extractables Testing Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Bioprocess Validation (Microbiological Testing Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Bioprocess Validation (Microbiological Testing Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Bioprocess Validation (Physiochemical Testing Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Bioprocess Validation (Physiochemical Testing Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Bioprocess Validation (Integrity Testing Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Bioprocess Validation (Integrity Testing Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Bioprocess Validation (Compatibility Testing Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Bioprocess Validation (Compatibility Testing Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Bioprocess Validation (Other Test Types) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Bioprocess Validation (Other Test Types) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Bioprocess Validation (Filter Elements) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Bioprocess Validation (Filter Elements) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Bioprocess Validation (Media Containers and Bags) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Bioprocess Validation (Media Containers and Bags) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Bioprocess Validation (Freezing and Thawing Process Bags) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Bioprocess Validation (Freezing and Thawing Process Bags) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Bioprocess Validation (Mixing Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Bioprocess Validation (Mixing Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Bioprocess Validation (Bioreactors) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Bioprocess Validation (Bioreactors) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Bioprocess Validation (Transfer Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Bioprocess Validation (Transfer Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Bioprocess Validation (Other Process Components) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Bioprocess Validation (Other Process Components) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Bioprocess Validation (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Bioprocess Validation (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Bioprocess Validation (Contract Development and Manufacturing Organizations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Bioprocess Validation (Contract Development and Manufacturing Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Bioprocess Validation (Other End Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Bioprocess Validation (Other End Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: North America: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: North America: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: United States: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: United States: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Canada: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Canada: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Asia-Pacific: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Asia-Pacific: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: China: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: China: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Japan: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Japan: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: India: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: India: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: South Korea: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: South Korea: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Australia: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Australia: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Indonesia: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Indonesia: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Others: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Others: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Europe: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Europe: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Germany: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Germany: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: France: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: France: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: United Kingdom: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: United Kingdom: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Italy: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Italy: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Spain: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Spain: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Russia: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Russia: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Others: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Others: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Latin America: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Latin America: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Brazil: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Brazil: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Mexico: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Mexico: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Others: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Others: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Middle East and Africa: Bioprocess Validation Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Middle East and Africa: Bioprocess Validation Market: Breakup by Country (in %), 2023
  • Figure 88: Middle East and Africa: Bioprocess Validation Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Bioprocess Validation Industry: SWOT Analysis
  • Figure 90: Global: Bioprocess Validation Industry: Value Chain Analysis
  • Figure 91: Global: Bioprocess Validation Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Bioprocess Validation Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Bioprocess Validation Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 3: Global: Bioprocess Validation Market Forecast: Breakup by Process Component (in Million US$), 2024-2032
  • Table 4: Global: Bioprocess Validation Market Forecast: Breakup by End User (in Million US$), 2024-2032
  • Table 5: Global: Bioprocess Validation Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Bioprocess Validation Market: Competitive Structure
  • Table 7: Global: Bioprocess Validation Market: Key Players
目次
Product Code: SR112024A6489

The global bioprocess validation market size reached US$ 363.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 721.6 Million by 2032, exhibiting a growth rate (CAGR) of 7.66% during 2024-2032.

Bioprocess validation refers to an approach of acquiring documentary evidence by demonstrating various procedures, processes, and activities that are conducted during the production and testing of the product to maintain the desired level of compliance at all phases. It involves extractable, microbiological, compatibility, integrity, and physiochemical testing services as standard methods. These techniques help evaluate multiple active pharmaceutical ingredients (APIs) and possible contaminants, including endotoxin, mycoplasma, and bacteria, during the development of biological products and animal drugs. Apart from this, bioprocess validation is cost-effective and monitors practices and medication manufacturing procedures. As a result, it is used by pharmaceutical, biopharmaceutical, and contract development and manufacturing organization (CMO) to assure drug quality, safety, efficacy, and predetermined attributes.

Bioprocess Validation Market Trends:

The increasing need for outsourcing bioprocess validation services in hospitals and clinics to maintain compliance with good manufacturing practices (GMP) is majorly driving the market growth. This is further supported by the execution of stringent quality and product safety regulations by governments. Additionally, the rising prevalence of various chronic ailments and the escalating demand for biopharmaceuticals are supplementing the widespread adoption of bioprocess validation across the healthcare sector, thus favoring the market growth. Moreover, the extensive usage of bioprocess validation by pharmaceutical and CMO companies to monitor the accuracy, purity, efficiency, and safety of drugs while manufacturing novel vaccines and biosimilars, especially during COVID-19, is acting as another growth-inducing factor. In line with this, significant technological advancements in bio-manufacturing infrastructure and the ongoing bioprocess validation of bioreactors to ensure the cost-effective and scalable production of medications are propelling the market growth. Apart from this, the emerging trend of outsourcing laboratory testing services, the escalating need for personalized medicines, and continuous research and development (R&D) activities to ensure the optimal quality of drugs are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global bioprocess validation market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on test type, process component and end user.

Breakup by Test Type:

Extractables Testing Services

Microbiological Testing Services

Physiochemical Testing Services

Integrity Testing Services

Compatibility Testing Services

Others

Breakup by Process Component:

Filter Elements

Media Containers and Bags

Freezing And Thawing Process Bags

Mixing Systems

Bioreactors

Transfer Systems

Others

Breakup by End User:

Pharmaceutical and Biotechnology Companies

Contract Development and Manufacturing Organizations

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Almac Group, Biozeen, Doc S.R.L., Eurofins Scientific, Hangzhou Anow Microfiltration Co. Ltd., Hangzhou Cobetter Filtration Equipment Co. Ltd., Hangzhou Tianshan Precision Filter Material Co. Ltd., Meissner Filtration Products, Inc., Merck KGaA, Sartorius AG, SGS SA and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1. How big is the global bioprocess validation market?
  • 2. What is the expected growth rate of the global bioprocess validation market during 2024-2032?
  • 3. What are the key factors driving the global bioprocess validation market?
  • 4. What has been the impact of COVID-19 on the global bioprocess validation market?
  • 5. What is the breakup of the global bioprocess validation market based on the test type?
  • 6. What is the breakup of the global bioprocess validation market based on the process component?
  • 7. What is the breakup of the global bioprocess validation market based on the end user?
  • 8. What are the key regions in the global bioprocess validation market?
  • 9. Who are the key players/companies in the global bioprocess validation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Bioprocess Validation Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Extractables Testing Services
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Microbiological Testing Services
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Physiochemical Testing Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Integrity Testing Services
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Compatibility Testing Services
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Process Component

  • 7.1 Filter Elements
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Media Containers and Bags
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Freezing And Thawing Process Bags
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Mixing Systems
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Bioreactors
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Transfer Systems
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Pharmaceutical and Biotechnology Companies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Contract Development and Manufacturing Organizations
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Almac Group
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 SWOT Analysis
    • 14.3.2 Biozeen
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Doc S.R.L.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Eurofins Scientific
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Hangzhou Anow Microfiltration Co. Ltd.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Hangzhou Cobetter Filtration Equipment Co. Ltd.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
    • 14.3.7 Hangzhou Tianshan Precision Filter Material Co. Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Meissner Filtration Products, Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Merck KGaA
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Sartorius AG
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 SGS SA
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
    • 14.3.12 Thermo Fisher Scientific Inc.
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis